[Experimental study on the influence of Gynostemma pentaphyllam Mak upon point mutation of Ha-ras oncogene in blocking leukoplakia from canceration]

Zhonghua Kou Qiang Yi Xue Za Zhi. 2000 Mar;35(2):91-4.
[Article in Chinese]

Abstract

Objective: To study the influence of Gynostemma pentaphyllam Mak (GP) upon point mutation of Ha-ras oncogene the molecular mechanism of GP in blocking canceration, and the relationship between Ha-ras oncogene and canceration of leukoplakia.

Methods: DMBA induced carcinogeneses of the buccal pouch mucosa of the hamsters were divided into leukoplakia model group(LKG) and GP treated group(GPG). Point mutation (codon 61) of Ha-ras oncogene was detected by PCR-SSCP in both groups.

Results: The mutation incidence of LKG was 22.96%, while the mean incidence of GPG was 7.59% (The incidences of C20-OH group, glucoside group and aglucon group were 5.32%, 6.25% and 11.00% respectively). When treated with DMBA for 4 to 8 weeks, the mutation incidence of LKG ranged from 11.10% to 40.00%, while GPG ranged from 0 to 10.70%.

Conclusions: GP has outstanding cancer blocking effect chiefly affected by free C20-OH. Mutation of Ha-ras oncogene plays an important role in leukoplakia canceration.

Publication types

  • English Abstract

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene / administration & dosage
  • Animals
  • Carcinogens / administration & dosage
  • Cricetinae
  • DNA / genetics
  • Genes, ras / genetics*
  • Gynostemma*
  • Leukoplakia, Oral / genetics
  • Leukoplakia, Oral / prevention & control*
  • Mouth Mucosa / drug effects*
  • Mouth Mucosa / metabolism
  • Mouth Mucosa / pathology
  • Phytotherapy
  • Plant Preparations / pharmacology*
  • Plant Preparations / therapeutic use
  • Point Mutation / drug effects
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational

Substances

  • Carcinogens
  • Plant Preparations
  • 9,10-Dimethyl-1,2-benzanthracene
  • DNA